SeraCare Produce High-Titre SARS-CoV-2 Stocks to Aid Global Diagnostic Assay Development

LGC39s SeraCare Life Sciences is expanding production of their novel COVID-19 reference materials to include high titer stocks that serve as a valuable tool for diagnostic manufacturers

from rapidmicrobiology https://ift.tt/2w0b9uH